Healthcare -
Drug Manufacturers - General - NYSE - US
$ 56.29
-0.16 %
$ 114 B
Market Cap
-15.72
P/E
BMY - COST OF REVENUE
Cost of Revenue BMY - Bristol-Myers Squibb Company
10.7 B
LAST VALUE
3.72%
2 YEAR CAGR
10.31%
5 YEAR CAGR
8.76%
10 YEAR CAGR